| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.76B | $1.67B | $1.63B |
| YoY Revenue Growth % | +5.7% | +2.5% | — |
| Gross Profit | $498.3M | $462.1M | — |
| Gross Margin % | 28.2% | 27.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $299.0M | $266.2M | $248.4M |
| Operating Margin % | 16.9% | 15.9% | 15.3% |
| Net Income (GAAP) | $207.4M | $185.6M | $171.3M |
| EBITDA (Normalized) | $342.1M | $305.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $202.7M | $105.4M | $189.0M |
| Capital Expenditures (CapEx) | $53.9M | $48.6M | — |
| Free Cash Flow (FCF) | $148.8M | $56.8M | $189.0M |
| FCF Margin % | 8.4% | 3.4% | 11.6% |
| Return on Invested Capital (ROIC %) | 34.6% | 34.3% | — |
| Cash & Short-Term Equivalents | $236.4M | $184.3M | — |
| Total Debt (Short + Long Term) | $540.0M | $570.0M | — |
| Total Stockholders' Equity | $378.5M | $227.4M | — |